Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Krajcsi

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|September 4, 1986
Characterization of the partially purified, ligand-free glucocorticoid receptorP Krajcsi, P Arányi
Virology|April 1, 1992
The adenovirus E3-14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserineP Krajcsi, W S Wold
The Journal of General Virology|June 20, 1998
Viral proteins that regulate cellular signallingP Krajcsi, W S Wold
Seminars in Cell & Developmental Biology|July 17, 1998
Inhibition of tumor necrosis factor and interferon triggered responses by DNA virusesP Krajcsi, W S Wold
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1987
Glucocorticoid receptors in thromboangiitis obliteransA Krasznai, P Krajcsi, P Arányi, et al.
Oncology|January 1, 1988
Lymphocyte glucocorticoid receptors in cancer patientsA Krasznai, P Krajcsi, P Arányi, et al.
Virology|June 1, 1992
The E3-14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosylated but not N-glycosylatedP Krajcsi, A E Tollefson, W S Wold
Acta Chirurgica Hungarica|January 1, 1989
Effects of operations on lymphocyte glucocorticoid receptorsA Krasznai, P Krajcsi, P Arányi, et al.
Haematologia|January 1, 1986
Decreased number of steroid receptors of circulating lymphocytes in Crohn's disease and ulcerative colitisA Krasznai, P Krajcsi, P Arányi, et al.
Biochemical Pharmacology|March 29, 2001
Molecular targets for pharmacological cytoprotectionA Balla, B Tóth, G Timár, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|September 4, 1986
Characterization of the partially purified, ligand-free glucocorticoid receptorP Krajcsi, P Arányi
Virology|April 1, 1992
The adenovirus E3-14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserineP Krajcsi, W S Wold
The Journal of General Virology|June 20, 1998
Viral proteins that regulate cellular signallingP Krajcsi, W S Wold
Seminars in Cell & Developmental Biology|July 17, 1998
Inhibition of tumor necrosis factor and interferon triggered responses by DNA virusesP Krajcsi, W S Wold
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1987
Glucocorticoid receptors in thromboangiitis obliteransA Krasznai, P Krajcsi, P Arányi, et al.
Oncology|January 1, 1988
Lymphocyte glucocorticoid receptors in cancer patientsA Krasznai, P Krajcsi, P Arányi, et al.
Virology|June 1, 1992
The E3-14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosylated but not N-glycosylatedP Krajcsi, A E Tollefson, W S Wold
Acta Chirurgica Hungarica|January 1, 1989
Effects of operations on lymphocyte glucocorticoid receptorsA Krasznai, P Krajcsi, P Arányi, et al.
Haematologia|January 1, 1986
Decreased number of steroid receptors of circulating lymphocytes in Crohn's disease and ulcerative colitisA Krasznai, P Krajcsi, P Arányi, et al.
Biochemical Pharmacology|March 29, 2001
Molecular targets for pharmacological cytoprotectionA Balla, B Tóth, G Timár, et al.
Pageof 3